# New clinical trials in Ukraine: 173 since Nov 2024

Updated November 2, 2026.

173 clinical studies with a site in Ukraine were first posted on ClinicalTrials.gov from November 22, 2024 to November 2, 2026; 107 have an industry sponsor and 117 are recruiting or about to. The newest, NCT07911085, was posted on November 2, 2026: From Blast Injury to Multicompartment Dysfunction: (Ukrainian Society of Regional Anesthesia and Pain Therapy).

## The full list

New clinical trials with a site in Ukraine: 173 rows for $8.65, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Enrollment, Enrollment type, Location countries, Central contact, Contact phone, Contact email, Last update posted, Read on, Source. The new rows each week by email, about 4 rows a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/country/ukraine

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

- New trials: 173
- Industry sponsored: 107
- Recruiting or not yet: 117
- Latest posted: November 2, 2026

## Newest trials

The newest 100 of 173, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Countries | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| November 2, 2026 | NCT07911085 | From Blast Injury to Multicompartment Dysfunction: | Ukrainian Society of Regional Anesthesia and Pain Therapy | Observational | Not yet recruiting | Compartment Syndrome, Compartment Syndrome Nontraumatic Lower Extremity, Compartment Syndrome Traumatic Upper... | 100 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07911085) |
| October 28, 2026 | NCT07900633 | A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk | Eli Lilly and Company | Phase 3 | Not yet recruiting | Obesity, Overweight, Cardiovascular Diseases, Diabetes Mellitus, Type 2 | 3,000 | Argentina, Australia, Brazil, Canada, China, Czechia, France, Germany, Hungary... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07900633) |
| October 23, 2026 | NCT07892404 | Purse-String Versus Linear Closure After Ileostomy Reversal | Dnipro Regional Clinical Oncology Dispensary | Not applicable | Completed | Diverting Ileostomy, Rectal Cancer | 23 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07892404) |
| October 14, 2026 | NCT07874139 | Prospective Study on Antimicrobial RESIstance in Chronic Pulmonary DiseasE | Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico | Observational | Recruiting | Chronic Lung Diseases | 683 | Albania, Australia, Belgium, Brazil, Canada, China, Croatia, Czechia, Denmark... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07874139) |
| October 7, 2026 | NCT07863921 | Acute Post-Amputation Pain Management After Combat-Related Lower Limb Injury | Kharkiv National Medical University | Not applicable | Not yet recruiting | Postamputation Pain, Lower Limb Amputation, Combat Trauma | 36 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07863921) |
| September 21, 2026 | NCT07829783 | A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) and Pembrolizumab (MK-3475A) in Participants With Bladder Cancer... | Merck Sharp & Dohme LLC | Phase 3 | Recruiting | Bladder Cancer | 400 | Taiwan, Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07829783) |
| August 24, 2026 | NCT07782333 | A Study Evaluating TRIV-573 in Atopic Dermatitis | Triveni Bio | Phase 2 | Recruiting | Atopic Dermatitis | 90 | Canada, Ukraine, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07782333) |
| August 18, 2026 | NCT07771283 | Purpose to Evaluate the Effectiveness of the Superovulation Stimulation Protocol Using Human Chorionic Gonadotropin (hCG) by Demonstrating... | LTD "EKODNIPRO", Medical centre Medical Plaza Dnipro | Not applicable | Enrolling by invitation | Infertility (IVF Patients), Infertility Assisted Reproductive Technology, Infertile Patients, Infertility Drugs... | 360 | Uganda, Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07771283) |
| August 13, 2026 | NCT07762027 | A Study to Assess the Safety, Pharmacokinetics, and Efficacy of ABI-6250 in Participants With Chronic Hepatitis D Virus Infection | Assembly Biosciences | Phase 2 | Not yet recruiting | Chronic Hepatitis D Infection | 80 | France, Georgia, Germany, Italy, Moldova, New Zealand, Pakistan, Romania... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07762027) |
| August 12, 2026 | NCT07761117 | A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF | AstraZeneca | Phase 3 | Recruiting | Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF) | 6,950 | Argentina, Australia, Austria, Brazil, Bulgaria, Canada, China, Czechia... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07761117) |
| August 10, 2026 | NCT07753993 | A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease. | AstraZeneca | Phase 3 | Recruiting | Chronic Kidney Disease | 7,000 | Argentina, Australia, Brazil, Bulgaria, Canada, Chile, China, Czechia, Denmark... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07753993) |
| August 7, 2026 | NCT07751978 | Adaptation and Evaluation of an Intersectional Stigma Reduction Intervention to Increase HIV Care Engagement Among Women Who Use Drugs | Johns Hopkins Bloomberg School of Public Health | Not applicable | Recruiting | HIV | 100 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07751978) |
| July 30, 2026 | NCT07736937 | Study of TUB-040 Given With Standard Ovarian Cancer Drugs in Patients With Fast-growing Ovarian Cancer | Gilead Sciences | Phase 1/2 | Recruiting | Ovarian Cancer | 72 | Belgium, Ukraine, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07736937) |
| July 23, 2026 | NCT07722715 | Study on the Treatment of Dental Implants Using the AmbiJet System for Peri-implantitis and Peri-implant Mucositis | Freiburger Medizintechnik GmbH | Not applicable | Recruiting | Peri Implant Mucositis, Peri Implantitis | 26 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07722715) |
| July 16, 2026 | NCT07706608 | DRONE-WOUND Study: Severe Infection After Drone-Related Combat Trauma | Ukrainian Society of Regional Anesthesia and Pain Therapy | Observational | Not yet recruiting | Combat Related Symptoms, Combat Trauma, Infection, Infection Complication, Wound - in Medical Care, Wound Infection... | 500 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07706608) |
| July 15, 2026 | NCT07705516 | Interfascial Abdominal Wall Block for Gynecological Laparoskopy: A Randomized Clinical Trial | Medical and Diagnostic Center "MEDION" LLC | Not applicable | Completed | Postoperative Pain, Pelvic Pain | 50 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07705516) |
| July 14, 2026 | NCT07702071 | BLOCK-TRAUMA Study | Ukrainian Society of Regional Anesthesia and Pain Therapy | Observational | Completed | Polytrauma, Regional Anaesthesia, Nerve Block, Acute Pain, Combat Trauma | 500 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07702071) |
| July 8, 2026 | NCT07690163 | DIabetes GLycemic Assessment in Newly Confirmed Episodes | Nazarii Kobyliak | Not applicable | Recruiting | Type 2 Diabetes (T2DM), Obesity Type 2 Diabetes Mellitus, Obesity & Overweight, Insulin Resistance | 80 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07690163) |
| July 8, 2026 | NCT07689097 | ASV and Targeted Fluid Resuscitation in Severe Burns | Ukrainian Society of Regional Anesthesia and Pain Therapy | Observational | Not yet recruiting | Burn, War-Related Injuries, Mechanical Ventilation, Infusion Fluid | 100 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07689097) |
| June 29, 2026 | NCT07672457 | Substance Use Prevention for Recently Displaced Adults - SUPRA (R33) RCT | Boston Medical Center | Not applicable | Not yet recruiting | Prevention, Substance Use, Refugee Health | 144 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07672457) |
| June 23, 2026 | NCT07662135 | A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Compared With Placebo in Adults With Type 2 Diabetes Mellitus and... | AstraZeneca | Phase 3 | Recruiting | Type 2 Diabetes Mellitus, Type 2 Diabetes With Chronic Kidney Disease | 900 | Bulgaria, China, Denmark, Germany, India, Japan, Malaysia, Mexico, Spain... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07662135) |
| June 23, 2026 | NCT07662109 | A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2... | AstraZeneca | Phase 3 | Recruiting | Type 2 Diabetes Mellitus | 2,000 | Argentina, Brazil, China, Czechia, Denmark, Germany, Greece, Hungary, India... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07662109) |
| June 17, 2026 | NCT07652294 | Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD | Spyre Therapeutics, Inc. | Phase 2 | Enrolling by invitation | Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative | 645 | Argentina, Australia, Austria, Belgium, Brazil, Chile, Czechia, Georgia... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07652294) |
| June 15, 2026 | NCT07647510 | A Phase 3 Study to Evaluate Claseprubart in Adults With Generalized Myasthenia Gravis (EMERGE) | Dianthus Therapeutics | Phase 3 | Recruiting | Myasthenia Gravis, Generalized | 195 | Georgia, Ukraine, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07647510) |
| June 4, 2026 | NCT07628010 | Modern Methods of Treatment and Diagnosis of Patients With Injuries and Diseases of the Musculoskeletal System | Zaporizhzhiya State Medical University | Not applicable | Active not recruiting | Osteoarthritis, Knee, Fractures, Ununited, Arthroplasty, Replacement, Knee | 100 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07628010) |
| June 4, 2026 | NCT07626983 | Botulinum Toxin Type A Versus Local Anesthetic Injection for Chronic Neuroma Pain After Combat-Related Amputation | Ukrainian Society of Regional Anesthesia and Pain Therapy | Not applicable | Completed | Chronic Pain Due to Injury, Neuroma of Lower Limb, Neural Injury, Neuroma of Upper Limb, Combat Related Symptoms | 100 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07626983) |
| June 4, 2026 | NCT07626294 | The Association Between Amputation Level and Chronic Low Back Pain After Combat-Related Amputation | Ukrainian Society of Regional Anesthesia and Pain Therapy | Observational | Not yet recruiting | Low Back Pain, Amputation | 300 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07626294) |
| June 3, 2026 | NCT07624890 | Ultrasound-Guided Platelet-Rich Plasma Versus Local Anesthetic Injection for Chronic Neuroma Pain After Combat-Related Amputation | Ukrainian Society of Regional Anesthesia and Pain Therapy | Not applicable | Completed | Neuroma, Phantom Limb Pain After Amputation, Stump Pain, Platelet-rich Plasma (PRP) | 100 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07624890) |
| June 3, 2026 | NCT07624877 | Comparative Evaluation of Intraneuroma and Perineuroma Botulinum Toxin Type A Injection Techniques for Chronic Neuroma Pain After... | Ukrainian Society of Regional Anesthesia and Pain Therapy | Not applicable | Completed | Chronic Pain, Neuroma, Botulinium Toxin-A, Combat Trauma | 100 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07624877) |
| June 3, 2026 | NCT07624305 | A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD) | AstraZeneca | Phase 3 | Recruiting | Renal Insufficiency, Chronic | 2,800 | Argentina, Austria, Brazil, Bulgaria, Canada, China, France, Germany, Greece... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07624305) |
| June 3, 2026 | NCT07623967 | Rapid Recovery: Gut Microbiome Correction for PTSD | Uzhhorod National University | Not applicable | Active not recruiting | PTSD - Post Traumatic Stress Disorder | 140 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07623967) |
| June 2, 2026 | NCT07620756 | Burnout Intervention During War for Hospital Staff in Ukraine | Charite University, Berlin, Germany | Not applicable | Recruiting | Burnout Risk | 80 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07620756) |
| June 1, 2026 | NCT07619131 | A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in... | AstraZeneca | Phase 3 | Recruiting | Hypercholesterolaemia | 600 | Bulgaria, Canada, Denmark, Germany, Hungary, Israel, Poland, Spain, Ukraine... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07619131) |
| June 1, 2026 | NCT07618689 | Proximal Nerve Cryoablation Versus Perineuroma Cryoablation for Chronic Neuroma Pain After Combat-Related Amputation | Ukrainian Society of Regional Anesthesia and Pain Therapy | Not applicable | Completed | Neuroma, Cryoablation | 50 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07618689) |
| May 29, 2026 | NCT07615010 | A Clinical Trial to Evaluate agenT-797 Plus Standard of Care in Participants With Severe Pneumonia With Moderate to Severe Acute Hypoxemic... | MiNK Therapeutics | Phase 2 | Recruiting | Pneumonia | 90 | Ukraine, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07615010) |
| May 20, 2026 | NCT07599072 | PREdiabetes GLycemic Impact and Data Evaluation | Nazarii Kobyliak | Not applicable | Recruiting | Pre Diabetic, Obesity & Overweight, Insulin Resistance | 80 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07599072) |
| May 6, 2026 | NCT07569211 | Simplified HCV Integrated Management Model in Methadone Clinics in Ukraine | Ukrainian Institute on Public Health Policy | Not applicable | Completed | HCV, Opioid Use Disorder | 616 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07569211) |
| April 28, 2026 | NCT07554651 | Cross-Shaped Vaginal Pessary for Pelvic Organ Prolapse | Dnipro State Medical University | Not applicable | Completed | Pelvic Organ Prolapse, Vaginal Prolapse | 51 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07554651) |
| April 28, 2026 | NCT07554339 | A Clinical Trial of Calderasib (MK-1084) and Durvalumab in People With Non-Small Cell Lung Cancer (MK-1084-015/KANDLELIT-015) | Merck Sharp & Dohme LLC | Phase 3 | Recruiting | Non-small Cell Lung Cancer | 310 | Argentina, Australia, Brazil, China, France, Germany, Greece, Italy, Japan... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07554339) |
| April 27, 2026 | NCT07551934 | Women's Reproductive Choices and Mental Health During Pregnancy and After Birth in Wartime Ukraine | Taras Shevchenko National University of Kyiv | Observational | Recruiting | Perinatal Mental Health, Reproductive Behavior, Women, Cohort Studies | 328 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07551934) |
| April 17, 2026 | NCT07536841 | Validation of the Odesa Criteria 2026 for Autoimmune Pancreatitis | Military Medical Clinical Center of the Southern Region, Ukraine | Observational | Recruiting | Autoimmune Pancreatitis, IgG4-Related Diseases, Pancreatic Cancer, Chronic Pancreatitis | 82 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07536841) |
| April 16, 2026 | NCT07533955 | A Phase 1 Study of JADE201 in Participants With Rheumatoid Arthritis | Jade Biosciences, Inc. | Phase 1 | Recruiting | Rhematoid Arthritis | 36 | Bulgaria, Georgia, Germany, Moldova, Romania, Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07533955) |
| April 9, 2026 | NCT07520019 | Study Evaluating the Effect of Nutra Harmony "Biotin, Collagen and Keratin Beauty Complex" Dietary Supplement on Hair Thickness and Hair... | Nutra Harmony LLC | Not applicable | Active not recruiting | Hair Thinning | 40 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07520019) |
| April 1, 2026 | NCT07504640 | The Effect of Spinal Manipulation on Heart Rate Variability in Children With Cerebral Palsy. | International Clinic of Rehabilitation, Ukraine | Not applicable | Recruiting | Cerebral Palsy (CP) | 20 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07504640) |
| March 31, 2026 | NCT07503873 | A Study to Evaluate Pharmacokinetics (PK) and Safety of Subcutaneous (SC) Ublituximab Administered at Various Injection Sites and Relative... | TG Therapeutics, Inc. | Phase 2 | Recruiting | Multiple Sclerosis | 350 | Bosnia and Herzegovina, Georgia, North Macedonia, Poland, Serbia, Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07503873) |
| March 30, 2026 | NCT07502313 | Evacuation Time and Tourniquet Use as Risk Factors for PTSD in Combat-Related Amputation | Charitable Organisation Charitable Fund Superhumans (Co Cf Superhumans) | Observational | Not yet recruiting | Amputation, PTSD, Combat Posttraumatic Stess Disorder, Combat Trauma | 300 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07502313) |
| March 27, 2026 | NCT07498140 | Procedural Framing and Epidural Steroid Injection Outcomes | Northwestern University | Not applicable | Recruiting | Lumbosacral Radiculopathy | 210 | Thailand, Ukraine, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07498140) |
| March 23, 2026 | NCT07486960 | Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015) | Merck Sharp & Dohme LLC | Phase 2 | Active not recruiting | Psoriatic Arthritis | 140 | Canada, Chile, Colombia, Germany, Poland, Spain, Ukraine, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07486960) |
| March 18, 2026 | NCT07480356 | Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With... | Protara Therapeutics | Phase 3 | Recruiting | Bladder (Urothelial, Transitional Cell) Cancer, Non-Muscle Invasive Bladder Carcinoma, Non-muscle Invasive Bladder... | 284 | Ukraine, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07480356) |
| March 17, 2026 | NCT07476326 | Pharmacokinetics, Safety, and Immunogenicity Comparison of Bmab1700 and Opdivo® as Adjuvant Monotherapy in Participants With Melanoma | Biocon Biologics UK PLC | Phase 1 | Recruiting | Melanoma | 120 | Brazil, Chile, Georgia, Moldova, Romania, Serbia, South Africa, Spain, Turkey... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07476326) |
| March 17, 2026 | NCT07475910 | Venous Thromboembolism and Chronic Pain After Major Limb Trauma | Charitable Organisation Charitable Fund Superhumans (Co Cf Superhumans) | Observational | Not yet recruiting | VTE (Venous Thromboembolism), Phantom Limb Pain After Amputation, Chronic Pain, Chronic Pain Due to Injury | 150 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07475910) |
| March 17, 2026 | NCT07475897 | Negative Pressure Wound Therapy as a Predictor of Persistent Pain After War-Related Trauma | Charitable Organisation Charitable Fund Superhumans (Co Cf Superhumans) | Observational | Completed | Phantom Limb Pain After Amputation, Chronic Pain Due to Injury, Postoperative Pain, Trauma (Including Fractures)... | 150 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07475897) |
| March 17, 2026 | NCT07475871 | Tourniquet Exposure and Risk of Chronic Pain After Severe Limb Trauma | Charitable Organisation Charitable Fund Superhumans (Co Cf Superhumans) | Observational | Completed | Pain, Pain After Surgery, Phantom Limb Pain After Amputation, Military Combat Stress Reaction | 150 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07475871) |
| March 16, 2026 | NCT07475572 | Pharmacokinetic Similarity Study to Compare AVT32-DRL\_PB With Keytruda® in Participants With Fully Resected Melanoma | Alvotech Swiss AG | Phase 1 | Recruiting | Melanoma | 120 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07475572) |
| March 16, 2026 | NCT07474506 | From Battlefield to Recovery: Continuous Regional Anaesthesia for War-Related Lower Limb Trauma | Charitable Organisation Charitable Fund Superhumans (Co Cf Superhumans) | Observational | Not yet recruiting | Pain Management, Perioperative Analgesia, War-Related Injuries | 150 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07474506) |
| March 13, 2026 | NCT07470333 | Hope Groups: Parenting and Mental Health Support for Ukrainian Caregivers | University of Oxford | Not applicable | Completed | Violence Against Children, Parental Mental Health, Parenting Practices | 510 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07470333) |
| March 2, 2026 | NCT07443553 | Alcohol Neurolysis and Capsaicin for Postamputation Pain (PAP) | Northwestern University | Not applicable | Not yet recruiting | Postamputation Pain | 120 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07443553) |
| February 27, 2026 | NCT07438769 | Ultrasound Predictors of Persistent Burn Scar Pain After Blast and Drone-Related Injuries: A Prospective Cohort Study | Ukrainian Society of Regional Anesthesia and Pain Therapy | Observational | Not yet recruiting | Burn Scar Pain, Neuropathic Pain, Combat-Related Burn Injury, Scar-Related Pain | 150 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07438769) |
| February 25, 2026 | NCT07432685 | Kinematics-Based Prediction of Chronic Pain After Combat-Related Extremity Trauma | Charitable Organisation Charitable Fund Superhumans (Co Cf Superhumans) | Observational | Completed | Residual Limb Pain, Post-Traumatic Limb Pain, Extremity Trauma, Combat-Related Limb Injury, Phantom Limb Pain, Phantom... | 100 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07432685) |
| February 25, 2026 | NCT07431944 | Silencing Neuroma Pain-Botulinum Toxin Versus Local Anesthetic Injection | Charitable Organisation Charitable Fund Superhumans (Co Cf Superhumans) | Not applicable | Not yet recruiting | Pain Management, Pain, Phantom Limb Pain, Phantom Limb Pain After Amputation | 100 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07431944) |
| February 25, 2026 | NCT07431827 | MK-3475A±Calderasib (MK-1084) in Completely Resected Stage IIA-IIIB (N2) KRAS G12Cm NSCLC (MK-1084-013) | Merck Sharp & Dohme LLC | Phase 3 | Recruiting | Non-small Cell Lung Cancer | 400 | Argentina, Australia, Brazil, Canada, Chile, China, Colombia, France, Greece... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07431827) |
| February 20, 2026 | NCT07424248 | Chronic Pain After Combat-Related Traumatic Brain Injury (cTBI-Pain Study) A Prospective Cohort Study of Pain Chronification After... | Charitable Organisation Charitable Fund Superhumans (Co Cf Superhumans) | Observational | Not yet recruiting | Pain, Chronic Pain, Chronic Pain Due to Injury | 100 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07424248) |
| February 18, 2026 | NCT07416448 | Neuroma-Associated Pain Management After Combat-Related Trauma in Ukraine | Ukrainian Society of Regional Anesthesia and Pain Therapy | Not applicable | Completed | Pain Management, Quality of Life, Neuroma, Functional Outcome, Depression in Adults, Neuropathic Pain, Hypoesthesia | 100 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07416448) |
| February 17, 2026 | NCT07415044 | LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis | Eli Lilly and Company | Phase 2 | Recruiting | Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate, Ulcerative Colitis, Active Severe | 1,431 | Argentina, Brazil, Canada, China, Colombia, Croatia, Czechia, France, Greece... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07415044) |
| February 17, 2026 | NCT07413939 | RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer... | Hoffmann-La Roche | Phase 2/3 | Recruiting | HER2-positive Breast Cancer | 650 | Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Czechia... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07413939) |
| February 17, 2026 | NCT07412704 | A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis | Bristol-Myers Squibb | Phase 1/2 | Recruiting | Arthritis, Rheumatoid | 84 | Belgium, Brazil, China, Germany, Italy, Mexico, Poland, Spain, Switzerland... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07412704) |
| February 12, 2026 | NCT07405164 | Extension Study for Participants in Studies That Include Belzutifan (MK-6482-043/LITESPARK-043) | Merck Sharp & Dohme LLC | Phase 3 | Recruiting | Von Hippel-Lindau Disease, Malignant Neoplasms | 450 | Australia, Belgium, Brazil, Canada, Chile, Czechia, Denmark, Finland, France... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07405164) |
| February 9, 2026 | NCT07397429 | Group Therapy Using the "I-Reconstruction" Psychotherapy Method to Reduce Anxiety Levels | International Association Psychosomatics And Health Therapy | Not applicable | Recruiting | Anxiety, Anxiety Depression | 36 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07397429) |
| February 5, 2026 | NCT07389044 | A Study on IB-001 Dose Response and Tolerability in Healthy Adults and Those With Chronic Hepatitis B | IntegerBio | Phase 1 | Recruiting | Chronic Hepatitis B Virus Infection | 88 | Hong Kong, Moldova, New Zealand, Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07389044) |
| February 2, 2026 | NCT07380789 | Comprehensive Multicenter Study on the Management of Acute Pain Following Thoracic Combat-Related Trauma in Ukraine | Lviv National Medical University | Not applicable | Recruiting | Pain Management, Thoracic Trauma, Pulmonary Function, Quality of Life, Functional Outcome, Depression in Adults... | 50 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07380789) |
| January 29, 2026 | NCT07375901 | the Blood-Aqeous Barrier During Anti-Angiogenic Therapy in Exudative Age-Related Macular Degeneration | The Filatov Institute of Eye Diseases and Tissue Therapy | Not applicable | Completed | AMD | 30 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07375901) |
| January 28, 2026 | NCT07374471 | A Study of MB-001 in Moderately to Severely Active Ulcerative Colitis | Mage Biologics | Phase 1/2 | Recruiting | Ulcerative Colitis (UC) | 100 | Georgia, Moldova, Poland, Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07374471) |
| January 22, 2026 | NCT07359846 | A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-2) | Generate Biomedicines | Phase 3 | Recruiting | Severe Asthma | 786 | Argentina, Australia, Belgium, Estonia, France, Georgia, India, Ireland, Italy... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07359846) |
| January 16, 2026 | NCT07346859 | Study of BP-SCIG 20% in Patients With Primary Immunodeficiency (PID) | Biopharma Plasma LLC | Phase 3 | Recruiting | Primary Immunodeficiency Diseases | 56 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07346859) |
| January 13, 2026 | NCT07336784 | Impact of Simulation-Based Teaching on Knowledge Acquisition in Anesthesiology Residents During Wartime | Heart Institute, Ministry of Health of Ukraine | Not applicable | Completed | Medical Education, Anesthesiology Residency Training, Simulation-based Learning, Online Medical Education | 65 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07336784) |
| January 9, 2026 | NCT07329114 | Healing Electroceutical Dressing for the Recovery of Open Wounds (HERO) | Chandan Sen | Not applicable | Recruiting | Wound Heal, Wound Infection, Wound Healing Delayed, Wound of Skin, Infections | 150 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07329114) |
| January 5, 2026 | NCT07318181 | Building Ukraine's Strength in PTSD Treatment and Research | University of Luxembourg | Not applicable | Recruiting | Post Traumatic Stress Disorder, Post Traumatic Stress Disorder PTSD, Post-Traumatic Stress Disorder, PTSD | 120 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07318181) |
| January 2, 2026 | NCT07313579 | Hyperthermic Intraperitoneal Chemoperfusion (HIPEC) in Gastric Cancer | Ukrainian Society of Clinical Oncology | Observational | Recruiting | Gastric Cancer (GC), HIPEC, Peritoneal Metastases From Gastric Cancer, Hyperthermic Intraperitoneal Chemoperfusion | 200 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07313579) |
| December 24, 2025 | NCT07301736 | Therapeutic Equivalence of CHF5993 pMDI 100/6/12.5 µg HFA-152a in Subjects With Mild to Moderate Asthma | Chiesi Farmaceutici S.p.A. | Phase 2 | Recruiting | Asthma | 780 | Argentina, Bosnia and Herzegovina, Bulgaria, Czechia, Germany, Hungary, Latvia... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07301736) |
| December 23, 2025 | NCT07299019 | A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis | Zenas BioPharma (USA), LLC | Phase 3 | Recruiting | Secondary Progressive Multiple Sclerosis | 990 | Australia, Belgium, Bulgaria, Croatia, Czechia, Estonia, France, Georgia... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07299019) |
| December 23, 2025 | NCT07298330 | A Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-4) | Mirum Pharmaceuticals, Inc. | Phase 3 | Active not recruiting | Chronic Hepatitis D Infection | 80 | Belgium, Bulgaria, Georgia, Hungary, Israel, Pakistan, Taiwan, Ukraine, United... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07298330) |
| December 22, 2025 | NCT07296315 | Confirmatory Clinical Study in Active Ulcerative Colitis | MRM Health NV | Phase 2 | Recruiting | Colitis, Ulcerative | 204 | Czechia, Georgia, Moldova, Poland, Serbia, Ukraine, United States | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07296315) |
| December 19, 2025 | NCT07295236 | Impact of Endo-vac Therapy for Esophago-jejunal Anastomotic Leak | Ukrainian Society of Clinical Oncology | Observational | Recruiting | Esophagojejunal Anastomotic Leak | 100 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07295236) |
| December 16, 2025 | NCT07286032 | A Study to Evaluate the Efficacy and Safety of Hetrombopag Olamine Tablets Vs Placebo in Patients With Chemotherapy-Induced... | Jiangsu HengRui Medicine Co., Ltd. | Phase 3 | Recruiting | Patients With Chemotherapy-Induced Thrombocytopenia | 150 | Bulgaria, China, France, Italy, Poland, Romania, South Korea, Spain, Turkey... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07286032) |
| December 11, 2025 | NCT07276581 | A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis | AstraZeneca | Phase 2 | Recruiting | Rheumatoid Arthritis | 320 | Argentina, Brazil, Bulgaria, Canada, Chile, China, Germany, Hungary, Japan... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07276581) |
| December 10, 2025 | NCT07276009 | Probiotics in Functional Dyspepsia | Nordic Biotic Sp. z o.o. | Not applicable | Completed | Functional Dyspepsia | 60 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07276009) |
| December 10, 2025 | NCT07275333 | Human Papillomavirus Self-sampling for Enhancing Cervical Screening During the War in Ukraine | Karolinska Institutet | Not applicable | Recruiting | Cervical Cancer, Cervical Cancer Screening, Human Papillomavirus (HPV) Infection, Cervical Intraepithelial Neoplasia | 1,000 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07275333) |
| November 28, 2025 | NCT07252739 | KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat... | Merck Sharp & Dohme LLC | Phase 2 | Recruiting | Malignant Neoplasm | 140 | Chile, China, Finland, Greece, Hong Kong, Italy, Netherlands, South Korea... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07252739) |
| November 25, 2025 | NCT07249814 | Comparison of Fractionated Versus Bolus Administration of Different Doses of Hyperbaric Bupivacaine Combined With Opioids in Spinal... | Bogomolets National Medical University | Not applicable | Completed | Spinal Anesthesia for Cesarean Section | 99 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07249814) |
| November 21, 2025 | NCT07241390 | A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney... | Eli Lilly and Company | Phase 3 | Recruiting | Atherosclerosis Cardiovascular Disease, Chronic Kidney Disease | 7,140 | Argentina, Australia, Austria, Belgium, Brazil, Bulgaria, Canada, China... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07241390) |
| October 30, 2025 | NCT07222917 | A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in... | AstraZeneca | Phase 2 | Active not recruiting | Chronic Kidney Disease and Hypertension | 222 | Argentina, Bulgaria, Canada, Taiwan, Thailand, Turkey (Türkiye), Ukraine... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07222917) |
| October 29, 2025 | NCT07222332 | A Study of Baricitinib (LY3009104) to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes... | Eli Lilly and Company | Phase 3 | Recruiting | Diabetes Mellitus, Type 1 | 300 | Australia, Belgium, Brazil, Canada, Czechia, Finland, France, Germany, Israel... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07222332) |
| October 28, 2025 | NCT07221734 | Study to Compare Pharmacokinetics, Efficacy, Safety, and Immunogenicity of MB11 Versus EU-/US-Opdivo® in Subjects With Previously Untreated... | mAbxience Research S.L. | Phase 3 | Recruiting | Advanced (Unresectable or Metastatic) Melanoma | 632 | Bosnia and Herzegovina, Brazil, Chile, Georgia, Greece, Italy, Peru, Portugal... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07221734) |
| October 8, 2025 | NCT07211633 | A Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, Radiological and Clinical Effects of Subcutaneous Ublituximab in... | TG Therapeutics, Inc. | Phase 3 | Active not recruiting | Relapsing Multiple Sclerosis | 360 | Bosnia and Herzegovina, Bulgaria, Croatia, Czechia, Georgia, Hungary, North... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07211633) |
| October 6, 2025 | NCT07207954 | Study of LFD-200 in Healthy Adults and Adults With Moderate to Severe Rheumatoid Arthritis | Lifordi Immunotherapeutics, Inc. | Phase 1 | Recruiting | Rheumatoid Arthritis | 176 | Australia, Georgia, Moldova, Poland, Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07207954) |
| October 1, 2025 | NCT07201558 | Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants | AstraZeneca | Phase 1 | Recruiting | Rheumatoid Arthritis, Systemic Lupus Erythematosus | 48 | Australia, Belgium, Brazil, China, Germany, Spain, Taiwan, Ukraine, United... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07201558) |
| September 24, 2025 | NCT07190248 | A Clinical Study of Calderasib (MK-1084) and Other Treatments for Participants With Non-Small Cell Lung Cancer (MK-1084-007/KANDLELIT-007) | Merck Sharp & Dohme LLC | Phase 3 | Recruiting | Non-small Cell Lung Cancer | 675 | Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07190248) |
| September 22, 2025 | NCT07185126 | Developing Innovative PTSD Treatment for Children | Viktoriia Gorbunova | Not applicable | Recruiting | Post Traumatic Stress Disorder PTSD | 40 | Ukraine | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07185126) |
| September 22, 2025 | NCT07185009 | A Maintenance Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative... | Sanofi | Phase 3 | Recruiting | Ulcerative Colitis | 751 | Argentina, Australia, Austria, Belgium, Bulgaria, Canada, Chile, China... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07185009) |
| September 22, 2025 | NCT07184996 | An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis | Sanofi | Phase 3 | Recruiting | Ulcerative Colitis | 980 | Argentina, Australia, Austria, Bulgaria, Canada, China, Czechia, France... | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07184996) |

## Sponsors posting most

| Sponsor | New trials | Latest |
| --- | --- | --- |
| Merck Sharp & Dohme LLC | 14 | September 21, 2026 |
| AstraZeneca | 13 | August 12, 2026 |
| Ukrainian Society of Regional Anesthesia and Pain Therapy | 11 | November 2, 2026 |
| Charitable Organisation Charitable Fund Superhumans (Co Cf Superhumans) | 8 | March 30, 2026 |
| Bristol-Myers Squibb | 7 | February 17, 2026 |
| Eli Lilly and Company | 5 | October 28, 2026 |
| Sanofi | 4 | September 22, 2025 |
| Spyre Therapeutics, Inc. | 3 | June 17, 2026 |
| The Filatov Institute of Eye Diseases and Tissue Therapy | 3 | January 29, 2026 |
| Ukrainian Society of Clinical Oncology | 3 | January 2, 2026 |
| Comeback Mobility Inc | 3 | August 22, 2025 |
| Climb Bio, Inc. | 3 | July 31, 2025 |
| Institute Hyalual GmbH | 3 | May 22, 2025 |
| Triveni Bio | 2 | August 24, 2026 |
| Nazarii Kobyliak | 2 | July 8, 2026 |
| Charite University, Berlin, Germany | 2 | June 2, 2026 |
| TG Therapeutics, Inc. | 2 | March 31, 2026 |
| Northwestern University | 2 | March 27, 2026 |
| Hoffmann-La Roche | 2 | February 17, 2026 |
| Zenas BioPharma (USA), LLC | 2 | December 23, 2025 |

## Conditions

| Condition group | New trials | Latest |
| --- | --- | --- |
| [Colitis, Ulcerative](https://specstream.ai/data/clinical-trials/condition/colitis-ulcerative) | 9 | June 17, 2026 |
| [Neuralgia](https://specstream.ai/data/clinical-trials/condition/neuralgia) | 7 | June 4, 2026 |
| [Chronic Pain](https://specstream.ai/data/clinical-trials/condition/chronic-pain) | 7 | June 3, 2026 |
| [Stress Disorders, Post-Traumatic](https://specstream.ai/data/clinical-trials/condition/stress-disorders-post-traumatic) | 7 | June 3, 2026 |
| [Renal Insufficiency, Chronic](https://specstream.ai/data/clinical-trials/condition/renal-insufficiency-chronic) | 6 | August 10, 2026 |
| Phantom Limb | 6 | June 4, 2026 |
| [Neoplasms](https://specstream.ai/data/clinical-trials/condition/neoplasms) | 6 | March 18, 2026 |
| [Arthritis, Rheumatoid](https://specstream.ai/data/clinical-trials/condition/arthritis-rheumatoid) | 6 | February 17, 2026 |
| [Carcinoma, Non-Small-Cell Lung](https://specstream.ai/data/clinical-trials/condition/carcinoma-non-small-cell-lung) | 5 | April 28, 2026 |
| [Agnosia](https://specstream.ai/data/clinical-trials/condition/agnosia) | 5 | March 16, 2026 |
| [Diabetes Mellitus, Type 2](https://specstream.ai/data/clinical-trials/condition/diabetes-mellitus-type-2) | 4 | October 28, 2026 |
| [Infections](https://specstream.ai/data/clinical-trials/condition/infections) | 4 | July 16, 2026 |
| [Inflammatory Bowel Diseases](https://specstream.ai/data/clinical-trials/condition/inflammatory-bowel-diseases) | 4 | June 17, 2026 |
| Neuroma | 4 | June 3, 2026 |
| Combat Disorders | 4 | June 3, 2026 |
| [Depression](https://specstream.ai/data/clinical-trials/condition/depression) | 4 | February 9, 2026 |
| Hepatitis D | 4 | December 23, 2025 |
| Parkinson Disease 4, Autosomal Dominant Lewy Body | 4 | November 28, 2025 |
| [Hypertension](https://specstream.ai/data/clinical-trials/condition/hypertension) | 4 | October 30, 2025 |
| Mania | 4 | August 26, 2025 |
| Blast Injuries | 3 | November 2, 2026 |
| [Obesity](https://specstream.ai/data/clinical-trials/condition/obesity) | 3 | October 28, 2026 |
| [Overweight](https://specstream.ai/data/clinical-trials/condition/overweight) | 3 | October 28, 2026 |
| [Cardiovascular Diseases](https://specstream.ai/data/clinical-trials/condition/cardiovascular-diseases) | 3 | October 28, 2026 |
| [Acute Pain](https://specstream.ai/data/clinical-trials/condition/acute-pain) | 3 | July 14, 2026 |

## By phase

| Phase | New trials | Latest |
| --- | --- | --- |
| [Not applicable](https://specstream.ai/data/clinical-trials/phase/not-applicable) | 56 | October 23, 2026 |
| [Phase 3](https://specstream.ai/data/clinical-trials/phase/phase-3) | 47 | October 28, 2026 |
| [Phase 2](https://specstream.ai/data/clinical-trials/phase/phase-2) | 26 | August 24, 2026 |
| [Observational](https://specstream.ai/data/clinical-trials/phase/observational) | 24 | November 2, 2026 |
| [Phase 1](https://specstream.ai/data/clinical-trials/phase/phase-1) | 12 | April 16, 2026 |
| [Phase 1/2](https://specstream.ai/data/clinical-trials/phase/phase-1-2) | 4 | July 30, 2026 |
| [Phase 2/3](https://specstream.ai/data/clinical-trials/phase/phase-2-3) | 3 | February 17, 2026 |
| [Phase 4](https://specstream.ai/data/clinical-trials/phase/phase-4) | 1 | June 19, 2025 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it.

Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).